| |
| | Migraine Assessment & Treatment Guidelines - Clinical References and Abstracts |
 | | Metoclopramide is contraindicated in patients with a history of seizures, pheochromocytoma, Parkinson’s disease, or in patients for whom stimulation of GI motility may be harmful, as in GI hemorrhage, obstruction or perforation |
 | | Metoclopramide may cause dystonias, especially in adolescents; metoclopramide is contraindicated in patients with a history of seizures, pheochromocytoma, or in patients for whom stimulation of GI motility may be harmful, as in GI hemorrhage, obstruction or perforation |
 | | Promethazine is contraindicated in patients with lower respiratory illnesses, including asthma; avoid use in patients with narrow angle glaucoma, symptomatic prostatic hypertrophy, stenosing peptic ulcer, bladder neck obstruction, pyloroduodenal obstruction, or bone marrow depression. |
| www.cme.wisc.edu /distance/migraine/step5.htm (1090 words) |
|